Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPARα-mediated fatty acid oxidation
Jing Yu, Yongjun Du, Chang Liu, Yu Xie, Mengci Yuan, Meihua Shan, Ning Li, Chang Liu, Yue Wang, Junfang Qin
Topics & Concepts
TamoxifenBreast cancerPeroxisome proliferator-activated receptorCancer researchInternal medicineEstrogen receptorEndocrinologyChemistryMedicineReceptorCancerCancer, Lipids, and MetabolismPeroxisome Proliferator-Activated ReceptorsCancer, Hypoxia, and Metabolism